Cargando…
ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury
COVID-19 is a highly transmittable respiratory illness caused by SARS-CoV-2, and acute lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS-CoV-2 pathogenicity is the limited availability of animal models. Therefore, it is necessary to establish animal models that...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533189/ https://www.ncbi.nlm.nih.gov/pubmed/37763673 http://dx.doi.org/10.3390/medicina59091554 |
_version_ | 1785112139068866560 |
---|---|
author | Lin, Cheng-Han Chen, Yi-Ju Lin, Meng-Wei Chang, Ho-Ju Yang, Xin-Rui Lin, Chih-Sheng |
author_facet | Lin, Cheng-Han Chen, Yi-Ju Lin, Meng-Wei Chang, Ho-Ju Yang, Xin-Rui Lin, Chih-Sheng |
author_sort | Lin, Cheng-Han |
collection | PubMed |
description | COVID-19 is a highly transmittable respiratory illness caused by SARS-CoV-2, and acute lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS-CoV-2 pathogenicity is the limited availability of animal models. Therefore, it is necessary to establish animal models that can reproduce multiple characteristics of ALI to study therapeutic applications. The present study established a mouse model that has features of ALI that are similar to COVID-19 syndrome to investigate the role of ACE2 and the administration of the Chinese herbal prescription NRICM101 in ALI. Mice with genetic modifications, including overexpression of human ACE2 (K18-hACE2 TG) and absence of ACE2 (mACE2 KO), were intratracheally instillated with hydrochloric acid. The acid intratracheal instillation induced severe immune cell infiltration, cytokine storms, and pulmonary disease in mice. Compared with K18-hACE2 TG mice, mACE2 KO mice exhibited dramatically increased levels of multiple inflammatory cytokines (IL-6 and TNF-α) in bronchoalveolar lavage fluid, histological evidence of lung injury, and dysregulation of MAPK and MMP activation. In mACE2 KO mice, NRICM101 could ameliorate the disease progression of acid-induced ALI. In conclusion, the established mouse model provided an effective platform for researchers to investigate pathological mechanisms and develop therapeutic strategies for ALI, including COVID-19-related ALI. |
format | Online Article Text |
id | pubmed-10533189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105331892023-09-28 ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury Lin, Cheng-Han Chen, Yi-Ju Lin, Meng-Wei Chang, Ho-Ju Yang, Xin-Rui Lin, Chih-Sheng Medicina (Kaunas) Article COVID-19 is a highly transmittable respiratory illness caused by SARS-CoV-2, and acute lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS-CoV-2 pathogenicity is the limited availability of animal models. Therefore, it is necessary to establish animal models that can reproduce multiple characteristics of ALI to study therapeutic applications. The present study established a mouse model that has features of ALI that are similar to COVID-19 syndrome to investigate the role of ACE2 and the administration of the Chinese herbal prescription NRICM101 in ALI. Mice with genetic modifications, including overexpression of human ACE2 (K18-hACE2 TG) and absence of ACE2 (mACE2 KO), were intratracheally instillated with hydrochloric acid. The acid intratracheal instillation induced severe immune cell infiltration, cytokine storms, and pulmonary disease in mice. Compared with K18-hACE2 TG mice, mACE2 KO mice exhibited dramatically increased levels of multiple inflammatory cytokines (IL-6 and TNF-α) in bronchoalveolar lavage fluid, histological evidence of lung injury, and dysregulation of MAPK and MMP activation. In mACE2 KO mice, NRICM101 could ameliorate the disease progression of acid-induced ALI. In conclusion, the established mouse model provided an effective platform for researchers to investigate pathological mechanisms and develop therapeutic strategies for ALI, including COVID-19-related ALI. MDPI 2023-08-26 /pmc/articles/PMC10533189/ /pubmed/37763673 http://dx.doi.org/10.3390/medicina59091554 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lin, Cheng-Han Chen, Yi-Ju Lin, Meng-Wei Chang, Ho-Ju Yang, Xin-Rui Lin, Chih-Sheng ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury |
title | ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury |
title_full | ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury |
title_fullStr | ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury |
title_full_unstemmed | ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury |
title_short | ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury |
title_sort | ace2 and a traditional chinese medicine formula nricm101 could alleviate the inflammation and pathogenic process of acute lung injury |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533189/ https://www.ncbi.nlm.nih.gov/pubmed/37763673 http://dx.doi.org/10.3390/medicina59091554 |
work_keys_str_mv | AT linchenghan ace2andatraditionalchinesemedicineformulanricm101couldalleviatetheinflammationandpathogenicprocessofacutelunginjury AT chenyiju ace2andatraditionalchinesemedicineformulanricm101couldalleviatetheinflammationandpathogenicprocessofacutelunginjury AT linmengwei ace2andatraditionalchinesemedicineformulanricm101couldalleviatetheinflammationandpathogenicprocessofacutelunginjury AT changhoju ace2andatraditionalchinesemedicineformulanricm101couldalleviatetheinflammationandpathogenicprocessofacutelunginjury AT yangxinrui ace2andatraditionalchinesemedicineformulanricm101couldalleviatetheinflammationandpathogenicprocessofacutelunginjury AT linchihsheng ace2andatraditionalchinesemedicineformulanricm101couldalleviatetheinflammationandpathogenicprocessofacutelunginjury |